fondaparinux has been researched along with Myelodysplastic-Syndromes* in 1 studies
1 other study(ies) available for fondaparinux and Myelodysplastic-Syndromes
Article | Year |
---|---|
Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Anticoagulants; Fondaparinux; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Polypharmacy; Polysaccharides; Recurrence; Thrombosis; Treatment Outcome | 2010 |